Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson Michael

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Virus Eradication|February 19, 2016
Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infectionJintanat Ananworanich, Carlo P Sacdalan, Suteeraporn Pinyakorn, et al.
Plos One|April 6, 2012
Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infectionJintanat Ananworanich, Alexandra Schuetz, Claire Vandergeeten, et al.
Journal of Virology|November 24, 2012
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trialPoonam Pegu, Monica Vaccari, Shari Gordon, et al.
Journal of Virology|May 11, 2018
Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying <i>env</i> from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 TropismHanna B Scinto, Sandeep Gupta, Swati Thorat, et al.
Science Translational Medicine|March 6, 2020
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infectionLouise Leyre, Eugène Kroon, Claire Vandergeeten, et al.
Nature Immunology|September 25, 2019
Author Correction: CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcomeSmita Kulkarni, Alexandra Lied, Viraj Kulkarni, et al.
Nature Immunology|June 19, 2019
CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcomeSmita Kulkarni, Alexandra Lied, Viraj Kulkarni, et al.
Nature Medicine|April 3, 2020
Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruptionDonn J Colby, Michal Sarnecki, Dan H Barouch, et al.
The Journal of Clinical Investigation|February 21, 2018
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1Maureen P Martin, Vivek Naranbhai, Patrick R Shea, et al.
Journal of Virology|November 24, 2017
Differential Immunodominance Hierarchy of CD8<sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 InfectionEmily Adland, Matilda Hill, Nora Lavandier, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Virus Eradication|February 19, 2016
Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infectionJintanat Ananworanich, Carlo P Sacdalan, Suteeraporn Pinyakorn, et al.
Plos One|April 6, 2012
Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infectionJintanat Ananworanich, Alexandra Schuetz, Claire Vandergeeten, et al.
Journal of Virology|November 24, 2012
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trialPoonam Pegu, Monica Vaccari, Shari Gordon, et al.
Journal of Virology|May 11, 2018
Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying <i>env</i> from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 TropismHanna B Scinto, Sandeep Gupta, Swati Thorat, et al.
Science Translational Medicine|March 6, 2020
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infectionLouise Leyre, Eugène Kroon, Claire Vandergeeten, et al.
Nature Immunology|September 25, 2019
Author Correction: CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcomeSmita Kulkarni, Alexandra Lied, Viraj Kulkarni, et al.
Nature Immunology|June 19, 2019
CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcomeSmita Kulkarni, Alexandra Lied, Viraj Kulkarni, et al.
Nature Medicine|April 3, 2020
Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruptionDonn J Colby, Michal Sarnecki, Dan H Barouch, et al.
The Journal of Clinical Investigation|February 21, 2018
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1Maureen P Martin, Vivek Naranbhai, Patrick R Shea, et al.
Journal of Virology|November 24, 2017
Differential Immunodominance Hierarchy of CD8<sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 InfectionEmily Adland, Matilda Hill, Nora Lavandier, et al.
Pageof 4